was initially included for the support and application of imaging of animal models of cancer. The resource is provided by the Vanderbilt University Institute of Imaging Science (VUIIS), a trans-institutional program established in 2002 that brings together a diverse and expert group of imaging scientists dedicated to the development and application of advanced imaging techniques in biomedical research. Over the past five years, the Cancer Center has been the major user of animal imaging, and cancer applications dominate usage of the imaging facilities. For example, in the past year, over 25 different principal investigators from the Vanderbilt-lngram Cancer Center (VICC) have used the resource, engaging the staff and equipment on more than 50 different projects/studies. In total, these studies used 4,650 hours of high-field MRI and MRS, nuclear imaging (PET, SPECT, and CT), optical imaging, and ultrasound. Today the resource is a very active component of the CCSG. This renewal seeks support for a major expansion to include human research imaging. In particular, we will provide organizational, administrative and financial support to encourage stronger and more formal collaborations between radiologists, imaging scientists and clinical oncologists working as teams engaged in the evaluation of clinical trials. We will also work with VICC investigators to identify appropriate imaging biomarkers and implement quantitative imaging methods that can be used as surrogate measures for clinical outcomes and that may be incorporated into clinical trials of novel anticancer agents. Thus, the aims of the Imaging Resource are to enable VICC investigators to: 1. Execute quantitative in vivo imaging studies in models of cancer, 2. Apply and validate MRI, optical, CT, PET, SPECT, and ultrasound methods for the noninvasive detection and characterization of treatment response in small animals; 3. Incorporate emerging, and clinically relevant, quantitative MRI and PET protocols into appropriate Phase I, II, and 111 clinical trials established at VICC. A fundamental strength of this shared resource is that the imaging science expertise obtained in preclinical studies with leading cancer scientists and physicians can be directly translated into, and inform, clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733536
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$320,357
Indirect Cost
$89,304
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Han, Ying; Signorello, Lisa B; Strom, Sara S et al. (2015) Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer 136:1210-7
Sanders, Melinda E; Schuyler, Peggy A; Simpson, Jean F et al. (2015) Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol 28:662-9
Chaturvedi, R; de Sablet, T; Asim, M et al. (2015) Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. Oncogene 34:3429-40
Vilgelm, Anna E; Pawlikowski, Jeff S; Liu, Yan et al. (2015) Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells. Cancer Res 75:181-93
Wei, Jinxiong; Noto, Jennifer M; Zaika, Elena et al. (2015) Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut 64:1040-8
Carrillo, A M; Bouska, A; Arrate, M P et al. (2015) Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene 34:846-56
Balko, Justin M; Giltnane, Jennifer M; Wang, Kai et al. (2014) Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov 4:232-45
Weeke, Peter; Mosley, Jonathan D; Hanna, David et al. (2014) Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome. J Am Coll Cardiol 63:1430-7
Cheng, Feixiong; Jia, Peilin; Wang, Quan et al. (2014) Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol Biol Evol 31:2156-69
Peng, Dun-Fa; Hu, Tian-Ling; Soutto, Mohammed et al. (2014) Loss of glutathione peroxidase 7 promotes TNF-?-induced NF-?B activation in Barrett's carcinogenesis. Carcinogenesis 35:1620-8

Showing the most recent 10 out of 1594 publications